Literature DB >> 19072762

Repair of DNA lesions associated with triplex-forming oligonucleotides.

Joanna Y Chin1, Peter M Glazer.   

Abstract

Triplex-forming oligonucleotides (TFOs) are gene targeting tools that can bind in the major groove of duplex DNA in a sequence-specific manner. When bound to DNA, TFOs can inhibit gene expression, can position DNA-reactive agents to specific locations in the genome, or can induce targeted mutagenesis and recombination. There is evidence that third strand binding, alone or with an associated cross-link, is recognized and metabolized by DNA repair factors, particularly the nucleotide excision repair pathway. This review examines the evidence for DNA repair of triplex-associated lesions. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19072762      PMCID: PMC2745299          DOI: 10.1002/mc.20501

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  56 in total

1.  Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51.

Authors:  H J Datta; P P Chan; K M Vasquez; R C Gupta; P M Glazer
Journal:  J Biol Chem       Date:  2001-02-27       Impact factor: 5.157

Review 2.  Homologous recombination in DNA repair and DNA damage tolerance.

Authors:  Xuan Li; Wolf-Dietrich Heyer
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

3.  Repair of sequence-specific 125I-induced double-strand breaks by nonhomologous DNA end joining in mammalian cell-free extracts.

Authors:  Andrea Odersky; Irina V Panyutin; Igor G Panyutin; Christian Schunck; Elke Feldmann; Wolfgang Goedecke; Ronald D Neumann; Gunter Obe; Petra Pfeiffer
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

4.  Triple helix-forming oligonucleotides target psoralen adducts to specific chromosomal sequences in human cells.

Authors:  D H Oh; P C Hanawalt
Journal:  Nucleic Acids Res       Date:  1999-12-15       Impact factor: 16.971

5.  Repair of triplex-directed DNA alkylation by nucleotide excision repair.

Authors:  A Ziemba; L C Derosier; R Methvin; C Y Song; E Clary; W Kahn; D Milesi; V Gorn; M Reed; S Ebbinghaus
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

6.  Detection and determination of oligonucleotide triplex formation-mediated transcription-coupled DNA repair in HeLa nuclear extracts.

Authors:  G Wang; Z Chen; S Zhang; G L Wilson; K Jing
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

7.  Psoralen adducts induced by triplex-forming oligonucleotides are refractory to repair in HeLa cells.

Authors:  A L Guieysse; D Praseuth; C Giovannangeli; U Asseline; C Hélène
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

Review 8.  Damage recognition in nucleotide excision repair of DNA.

Authors:  D P Batty; R D Wood
Journal:  Gene       Date:  2000-01-11       Impact factor: 3.688

9.  Specific mutations induced by triplex-forming oligonucleotides in mice.

Authors:  K M Vasquez; L Narayanan; P M Glazer
Journal:  Science       Date:  2000-10-20       Impact factor: 47.728

10.  Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions.

Authors:  Karen M Vasquez; Jesper Christensen; Lei Li; Rick A Finch; Peter M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

View more
  30 in total

1.  Targeted gene correction using psoralen, chlorambucil and camptothecin conjugates of triplex forming peptide nucleic acid (PNA).

Authors:  Henrik Birkedal; Peter E Nielsen
Journal:  Artif DNA PNA XNA       Date:  2011-01

Review 2.  Potential in vivo roles of nucleic acid triple-helices.

Authors:  Fabian A Buske; John S Mattick; Timothy L Bailey
Journal:  RNA Biol       Date:  2011-05-01       Impact factor: 4.652

Review 3.  Genome engineering with zinc-finger nucleases.

Authors:  Dana Carroll
Journal:  Genetics       Date:  2011-08       Impact factor: 4.562

4.  Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides.

Authors:  Osamu Nakagawa; Xin Ming; Kyle Carver; Rudy Juliano
Journal:  Bioconjug Chem       Date:  2013-12-19       Impact factor: 4.774

5.  Homologous recombination assay for interstrand cross-link repair.

Authors:  Koji Nakanishi; Francesca Cavallo; Erika Brunet; Maria Jasin
Journal:  Methods Mol Biol       Date:  2011

Review 6.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21

7.  Targeting of an interrupted polypurine:polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue.

Authors:  A Semenyuk; E Darian; J Liu; A Majumdar; B Cuenoud; P S Miller; A D Mackerell; M M Seidman
Journal:  Biochemistry       Date:  2010-09-14       Impact factor: 3.162

8.  Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.

Authors:  N A McNeer; E B Schleifman; A Cuthbert; M Brehm; A Jackson; C Cheng; K Anandalingam; P Kumar; L D Shultz; D L Greiner; W Mark Saltzman; P M Glazer
Journal:  Gene Ther       Date:  2012-10-18       Impact factor: 5.250

9.  Targeted genome modification via triple helix formation.

Authors:  Adele S Ricciardi; Nicole A McNeer; Kavitha K Anandalingam; W Mark Saltzman; Peter M Glazer
Journal:  Methods Mol Biol       Date:  2014

10.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.